FlashFlashDetails
Innovent Biologics and Daiichi Sankyo Reach Vanflyta Commercialization Agreement in China
2026-08-10 10:53:44
According to CoinMeta, Innovent Biologics Inc ( IVBXF, 1801. HK ) has reached an exclusive agreement with Daiichi Sankyo ( DSKYF, 4568.T ) to obtain the commercialization rights of Vanflyta ( Quizartinib ) in China. Innovent Biologics stated in a declaration that both parties have signed the relevant agreement.
Bullish 0
Bearish 0
Source：Internet
This content is for market information only and does not constitute investment advice.
Hot Articles
Refresh
arrow
'No longer a distant place': F2Pool Co-founder Chun Wang joins SpaceX's 2-year mission to Mars
'No longer a distant place': F2Pool Co-founder Chun Wang joins SpaceX's 2-year mission to Mars
05-22 18:25
Polymarket Targets Japan Approval Despite Gambling Laws
Polymarket Targets Japan Approval Despite Gambling Laws
05-22 18:00
ZachXBT flags suspected exploit involving Polymarket's UMA adapter contract on Polygon
ZachXBT flags suspected exploit involving Polymarket's UMA adapter contract on Polygon
05-22 17:57
ZachXBT flags $520K Polymarket exploit on Polygon, team says funds are safe
ZachXBT flags $520K Polymarket exploit on Polygon, team says funds are safe
05-22 17:24
Verus bridge exploiter returns 4,052 ETH, retains $2.8 million bounty: onchain analyst
Verus bridge exploiter returns 4,052 ETH, retains $2.8 million bounty: onchain analyst
05-22 17:24